Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Semin Arthritis Rheum. 2018 Sep 17;48(6):1068–1073. doi: 10.1016/j.semarthrit.2018.09.001

Table 3.

Association of Total Agatston Score for Vascular Calcification and Clinical Variables

Variable Univariable Multivariable
Estimate (SE) P Value Estimate (SE) P Value
Age
(per year)
0.06 (1.06) 0.01 0.14 (1.15) <0.01
Type of Vasculitis
(TAK vs GCA)
−0.96 (0.38) 0.30 4.02 (55.70) 0.03
Prednisone dose
(per 1mg/day)
0.05 (1.16) 0.08 0.05 (1.05) 0.04
Anti-hypertensive Medication
(Yes vs No)
2.43 (11.35) <0.01 1.16 (3.19) 0.19
Gender
(Female vs Male)
0.85 (2.3) 0.04 0.12 (1.12) 0.90
C-reactive Protein
(per 1mg/L)
−0.03 (0.97) 0.11 Not included in multivariable model.
Statin Medication
(Yes vs No)
1.49 (4.43) 0.17
FDG-PET interpretation
(Active vs Inactive)
0.99 (2.69) 0.29
Treatment duration
(per year)
0(1) 0.53
Clinical Assessment
(Active vs remission)
0.44(1.55) 0.65
Disease duration
(per year)
0 (1) 0.74
Body mass index
(per Kg/m2)
0.02 (1.02) 0.77
Erythrocyte sedimentation rate
(per 1 mm/hr)
0.003 (1.0) 0.89

SE = standard error; TAK = Takayasu’s arteritis; GCA = giant cell arteritis, FDG-PET = 18F-fluorodeoxyglucose positron emission tomography.